PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV was reported 45 times

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 3 0.0018
1 CHLORAMBUCIL 6 0.0015
2 AMPHOTERICIN B 10 0.0008
3 OFATUMUMAB 10 0.0003
4 TORSEMIDE 10 0.0003
5 PREDNISOLONE ORAL SOLUTION 29 0.0002
6 APIXABAN 10 0.0001
7 METOCLOPRAMIDE HYDROCHLORIDE 10 0.0001
8 AZATHIOPRINE 10 0.0001
9 BRENTUXIMAB VEDOTIN 1 0.0001
10 CYCLOPHOSPHAMIDE FOR INJECTION 16 0.0001
11 CYCLOPHOSPHAMIDE 16 0.0001
12 PREDNISOLONE ACETATE 1 0.0001
13 ADALIMUMAB-FKJP 4 0.0001
14 ACYCLOVIR 10 0.0001
15 ADALIMUMAB-AATY 4 0.0001
16 ADALIMUMAB-ADAZ 4 0.0001
17 BENDAMUSTINE HCL 1 0.0001
18 AMITRIPTYLINE HYDROCHLORIDE 1 0.0001
19 DOXORUBICIN 5 0.0001
20 PANTOPRAZOLE 10 0.0000
21 RITUXIMAB 7 0.0000
22 DOXORUBICIN HYDROCHLORIDE 1 0.0000
23 FILGRASTIM 1 0.0000
24 PEMETREXED DISODIUM 1 0.0000
25 TOCILIZUMAB 2 0.0000
26 TACROLIMUS OINTMENT 0.1% 2 0.0000
27 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
28 ANTI-ITCH CREAM 1 0.0000
29 HYDROCORTISONE LOTION 1 0.0000
30 HYDROCORTISONE CREAM 1% 1 0.0000
31 INFLIXIMAB 3 0.0000
32 HYDROCORTISONE ACETATE 1 0.0000
33 CISPLATIN 1 0.0000
34 TACROLIMUS 2 0.0000
35 METHOTREXATE SODIUM 6 0.0000
36 HYDROCORTISONE 1 0.0000
37 NIVOLUMAB 1 0.0000
38 WARFARIN 1 0.0000
39 PREDNISONE 4 0.0000
40 ADALIMUMAB 4 0.0000
41 LENALIDOMIDE 1 0.0000
42 DUPILUMAB 1 0.0000
43 ETANERCEPT 1 0.0000